Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1 1

Status

Terminated 2Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 2NET 1Gastrointestinal 1

Conditions

Acromegaly 2Prostatic Neoplasms 1Pituitary Neoplasms 1Neuroendocrine Tumors in Lung 1Neuroendocrine Tumors 1Neoplasm Metastasis 1Gigantism 1Gastrointestinal Neoplasms 1Gastro-enteropancreatic neuroendocrine tumor 1Carcinoid Tumor 1

Interventions

lanreotide 2Octreotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Acromegaly × lanreotide × Clear all
NCT05364944 2025-11-17

OXTEND-01

Debiopharm International SA

Phase 1 Terminated
19 enrolled
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Acromegaly

NCT01861717 2021-09-30

A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.

Saint John's Cancer Institute

Phase 4 Terminated
4 enrolled 5 charts
Endocrine

Acromegaly, Gigantism, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡